Correlation Between Argen X and Pharming Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Argen X and Pharming Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Argen X and Pharming Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Argen X and Pharming Group NV, you can compare the effects of market volatilities on Argen X and Pharming Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Argen X with a short position of Pharming Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Argen X and Pharming Group.

Diversification Opportunities for Argen X and Pharming Group

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Argen and Pharming is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Argen X and Pharming Group NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharming Group NV and Argen X is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Argen X are associated (or correlated) with Pharming Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharming Group NV has no effect on the direction of Argen X i.e., Argen X and Pharming Group go up and down completely randomly.

Pair Corralation between Argen X and Pharming Group

Assuming the 90 days trading horizon Argen X is expected to generate 0.52 times more return on investment than Pharming Group. However, Argen X is 1.92 times less risky than Pharming Group. It trades about 0.2 of its potential returns per unit of risk. Pharming Group NV is currently generating about 0.09 per unit of risk. If you would invest  48,220  in Argen X on September 19, 2024 and sell it today you would earn a total of  11,720  from holding Argen X or generate 24.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Argen X  vs.  Pharming Group NV

 Performance 
       Timeline  
Argen X 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Argen X are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Argen X reported solid returns over the last few months and may actually be approaching a breakup point.
Pharming Group NV 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharming Group NV are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Pharming Group sustained solid returns over the last few months and may actually be approaching a breakup point.

Argen X and Pharming Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Argen X and Pharming Group

The main advantage of trading using opposite Argen X and Pharming Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Argen X position performs unexpectedly, Pharming Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharming Group will offset losses from the drop in Pharming Group's long position.
The idea behind Argen X and Pharming Group NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing